These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Novel mechanism of brain soluble epoxide hydrolase-mediated blood pressure regulation in the spontaneously hypertensive rat. Sellers KW, Sun C, Diez-Freire C, Waki H, Morisseau C, Falck JR, Hammock BD, Paton JF, Raizada MK. FASEB J; 2005 Apr 24; 19(6):626-8. PubMed ID: 15659536 [Abstract] [Full Text] [Related]
5. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats. Sharkey LC, Radin MJ, Heller L, Rogers LK, Tobias A, Matise I, Wang Q, Apple FS, McCune SA. Toxicol Appl Pharmacol; 2013 Nov 15; 273(1):47-57. PubMed ID: 23993975 [Abstract] [Full Text] [Related]
6. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats. Elmarakby AA, Faulkner J, Pye C, Rouch K, Alhashim A, Maddipati KR, Baban B. Clin Sci (Lond); 2013 Oct 15; 125(7):349-59. PubMed ID: 23611540 [Abstract] [Full Text] [Related]
7. The red blood cell participates in regulation of the circulation by producing and releasing epoxyeicosatrienoic acids. Jiang H, Anderson GD, McGiff JC. Prostaglandins Other Lipid Mediat; 2012 Aug 15; 98(3-4):91-3. PubMed ID: 22178722 [Abstract] [Full Text] [Related]
8. Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats. Revermann M, Barbosa-Sicard E, Dony E, Schermuly RT, Morisseau C, Geisslinger G, Fleming I, Hammock BD, Brandes RP. J Hypertens; 2009 Feb 15; 27(2):322-31. PubMed ID: 19226702 [Abstract] [Full Text] [Related]
9. Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats. Koeners MP, Wesseling S, Ulu A, Sepúlveda RL, Morisseau C, Braam B, Hammock BD, Joles JA. Am J Physiol Endocrinol Metab; 2011 Apr 15; 300(4):E691-8. PubMed ID: 21266668 [Abstract] [Full Text] [Related]
10. 5,6-epoxyeicosatrienoic acid mediates the enhanced renal vasodilation to arachidonic acid in the SHR. Pomposiello SI, Quilley J, Carroll MA, Falck JR, McGiff JC. Hypertension; 2003 Oct 15; 42(4):548-54. PubMed ID: 12939232 [Abstract] [Full Text] [Related]
11. Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension. Neckář J, Kopkan L, Husková Z, Kolář F, Papoušek F, Kramer HJ, Hwang SH, Hammock BD, Imig JD, Malý J, Netuka I, Ošťádal B, Červenka L. Clin Sci (Lond); 2012 Jun 15; 122(11):513-25. PubMed ID: 22324471 [Abstract] [Full Text] [Related]
12. Sexual dimorphism in renal heme oxygenase-1 and arachidonic acid metabolizing enzymes in spontaneously hypertensive rats versus normotensive Wistar Kyoto rats. Alhashim A, Abdelbary M, Sullivan JC, Naeini SE, Elmarakby AA. Prostaglandins Other Lipid Mediat; 2022 Aug 15; 161():106650. PubMed ID: 35618157 [Abstract] [Full Text] [Related]
13. Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney. Yu Z, Huse LM, Adler P, Graham L, Ma J, Zeldin DC, Kroetz DL. Mol Pharmacol; 2000 May 15; 57(5):1011-20. PubMed ID: 10779386 [Abstract] [Full Text] [Related]
14. Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles. Gauthier KM, Olson L, Harder A, Isbell M, Imig JD, Gutterman DD, Falck JR, Campbell WB. Am J Physiol Renal Physiol; 2011 Oct 15; 301(4):F765-72. PubMed ID: 21753077 [Abstract] [Full Text] [Related]
15. Red blood cells: reservoirs of cis- and trans-epoxyeicosatrienoic acids. Jiang H, Quilley J, Reddy LM, Falck JR, Wong PY, McGiff JC. Prostaglandins Other Lipid Mediat; 2005 Jan 15; 75(1-4):65-78. PubMed ID: 15789616 [Abstract] [Full Text] [Related]